Central Administration of Amyloid β-Peptide (25–35) and Individual Features of Cognitive Behavior in Rats

ISSN： 0097-0549

Source： Neuroscience and Behavioral Physiology, Vol.40, Iss.9, 2010-11, pp. : 964-968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Studies of the Effects of Central Administration of β-Amyloid Peptide (25–35): Pathomorphological Changes in the Hippocampus and Impairment of Spatial Memory

By Stepanichev M. Zdobnova I. Zarubenko I. Lazareva N. Gulyaeva N.

Neuroscience and Behavioral Physiology, Vol. 36, Iss. 1, 2006-01 ,pp. : 101-106

Springer Publishing Company

Access to resources Recommend Favorite

Studies of the effects of fragment (25–35) of beta-amyloid peptide on the behavior of rats in a radial maze

By Stepanichev M. Moiseeva Yu. Lazareva N. Gulyaeva N.

Neuroscience and Behavioral Physiology, Vol. 35, Iss. 5, 2005-06 ,pp. : 511-518

Springer Publishing Company

Access to resources Recommend Favorite

Amyloid &bgr;-Peptide: The Inside Story

Current Alzheimer Research, Vol. 1, Iss. 4, 2004-11 ,pp. : 231-239

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective Effect of Ganglioside GM1 on the Cytotoxic Action of Hydrogen Peroxide and Amyloid β-peptide in PC12 cells

By Sokolova Tatyana Zakharova Irina Furaev Victor Rychkova Maria Avrova Natalia

Neurochemical Research, Vol. 32, Iss. 8, 2007-08 ,pp. : 1302-1313

Springer Publishing Company

Access to resources Recommend Favorite

Homocysteine and Folate Deficiency Sensitize Oligodendrocytes to the Cell Death-Promoting Effects of a Presenilin-1 Mutation and Amyloid β-Peptide

By Pak Kirk J. Chan Sic L. Mattson Mark P.

NeuroMolecular Medicine, Vol. 3, Iss. 2, 2003-04 ,pp. : 119-128

Humana Press, Inc

Access to resources Recommend Favorite